Regulatory Spine Medtronic Announces FDA approval of Infuse™ bone graft for one-and-two level Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures byJosh SandbergFebruary 17, 2026
Financial Patients who received Medtronic’s Infuse product to get $8.45 million in settlements byJosh SandbergAugust 5, 2016
Hospitals In letter to Franken, FDA defends handling of Medtronic’s Infuse study byJosh SandbergJune 23, 2016
Spine Medtronic Responds to Star Tribune Article Regarding INFUSE Bone Graft byJosh SandbergApril 11, 2016
